HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Abbott

US Formula Market Astir With Changes As Congress Stirs Tighter Product Quality Regulations

Brands also making market moves as lawmakers consider legislation instructing Transportation Security Administration to provide guidance to minimize risk for contamination of baby formula and related pediatric nutritional products.

Manufacturing Consumer

Abbott’s Share-Gobbling Aveir DR Leadless Pacing System Introduced To UK

The firm’s dual-chamber leadless pacemaker system with is expected to be a growth driver for Abbott and already has acquired approximately 30%-40% of market share from Medtronic since its approval by the US FDA in July 2023, according to GlobalData.

Commercial Launches

News We’re Watching: $1B Judgement Against J&J Recalls For Abbott, Baxter, More; Karl Storz Announces Fujifilm Partnership

This week, a Delaware court awarded Auris Health shareholders $1bn in a lawsuit against Johnson & Johnson; Abbott recalled some FreeStyle Libre 3 sensors; and McKesson purchased a controlling interest in a Florida cancer care chain.

Commercial Regulation

Abbott Launches Trial Of DBS Depression Treatment

The DBS trial will look at the use of neurostimulation in people with treatment-resistant depression, which affects about 2.8 million Americans each year. The implanted device may relieve depression symptoms by changing activity patterns in the brain.

Clinical Trials FDA
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • Abbott Diabetes Care, Inc.
    • Abbott Laboratories
    • Abbott Medical Optics
    • Advanced Medical Optics, Inc.
    • AMO Manufacturing USA, LLC
    • Advanced Neuromodulation Systems
    • AGA Medical Corporation
    • Alere, Inc.
    • Axis-Shield plc
    • Binax, Inc.
    • Biosite, Inc.
    • CardioMEMS
    • Cephea Valve Technologies
    • CFR Pharmaceuticals S.A.
    • Cholestech Corporation
    • Domestic Formulations
    • Endocardial Solutions, Inc.
    • Endosense SA
    • EP Medsystems
    • Epicor Medical, Inc.
    • Evalve Inc.
    • Facet Biotech Corporation
    • Fournier Pharma
    • Free & Clear, Inc.
    • Garden Hills
    • Guidant Corporation Vascular Device Division
    • Ibis Biosciences
    • IDEV Technologies
    • Innogenetics nv
    • Inverness Medical Innovations Inc.
    • Irvine Biomedical
    • Kos Pharmaceuticals, Inc.
    • MediGuide Inc.
    • MediSense
    • Nanostim
    • Inc.
    • Neuromed Inc.
    • NeuroTherm Inc
    • Northstar Neuroscience, Inc.
    • OptiMedica Corporation
    • Ostex International Inc.
    • Pacesetter
    • Piramal Healthcare Solutions
    • Quest Medical, Inc.
    • Radi Medical Systems AB
    • Spinal Modulation, Inc.
    • Solvay Pharmaceuticals, Inc. (Unimed Pharmaceuticals, Inc.)
    • Spinal Concepts
    • St. Jude Medical, Inc.
    • Tendyne Holdings, Inc.
    • TheraSense, Inc.
    • Thoratec Corporation
    • Topera, Inc.
    • US Diagnostics (USD)
    • Velocimed, Inc.
    • Ventritex
    • Veropharm
    • Walk Vascular, LLC
UsernamePublicRestriction

Register